Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02207114 · ClinicalTrials.gov registry record · NA
Using Biomarkers to Optimize Antibiotic Strategies in Sepsis
A NA study of Sepsis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
- 1
- Study location
NCT02207114 is a NA study of Sepsis that has completed, run by University of Pennsylvania. The registered enrollment target is 145 participants, below the 6,563-participant average among 90 other Sepsis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02207114, a NA study of Sepsis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed work will provide critical insights into the potential impact of a biomarker-based algorithm on reducing unnecessary antibiotic use in different adult and pediatric/neonatal ICU's. This proposal will also assess the costs (or savings) of a biomarker-based intervention. Overall, the results of this work will be critical in informing future strategies to eliminate unnecessary antibiotic use and curb the continued rise in antimicrobial resistance.
Conditions Studied
Interventions
- OTHER Biomarker Algorithm Intervention
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Medical Intensive Care Unit - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2012-01 |
| Est. Completion | 2023-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02207114
The ClinicalTrials.gov registry entry for NCT02207114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,563-participant average among 90 other Sepsis trials with a reported enrollment target (98% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Biomarker Algorithm Intervention is the first listed.
NCT02207114 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02207114 about?
NCT02207114 is a clinical study titled "Using Biomarkers to Optimize Antibiotic Strategies in Sepsis". The proposed work will provide critical insights into the potential impact of a biomarker-based algorithm on reducing unnecessary antibiotic use in different adult and pediatric/neonatal ICU's. This proposal will also assess the costs (or savings) of a biomarker-based intervention. Overall, the resu...
What is the current status of trial NCT02207114?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2012-01. Estimated completion is 2023-12.
What conditions does trial NCT02207114 study?
This clinical trial studies the following conditions: Sepsis.
What interventions are being tested in trial NCT02207114?
The interventions under investigation include: Biomarker Algorithm Intervention (OTHER).
Who is sponsoring clinical trial NCT02207114?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02207114 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
RECRUITING · NA
-
BLOOM: Pragmatic Feasibility Trial
RECRUITING · NA
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.